Kennedy Capital Management, Inc. Halozyme Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

$4.27 Billion
Q3 2024

A detailed history of Kennedy Capital Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 364,542 shares of HALO stock, worth $19.7 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

364,542

Previous 441,695 17.47%

Holding current value

$19.7 Million

Previous $23.1 Million 9.82%

% of portfolio

0.49%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$51.3 - $64.42 $3.96 Million - $4.97 Million	-77,153 Reduced 17.47%	364,542 $20.9 Million
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $2.7 Million - $3.74 Million	-71,401 Reduced 13.92%	441,695 $23.1 Million
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $5.04 Million - $6.28 Million	-149,720 Reduced 22.59%	513,096 $20.9 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $544,482 - $687,956	16,341 Added 2.53%	662,816 $24.5 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $1.05 Million - $1.27 Million	28,880 Added 4.68%	646,475 $24.7 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $3.45 Million - $4.41 Million	113,886 Added 22.61%	617,595 $22.3 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $2.32 Million - $3.93 Million	-70,485 Reduced 12.28%	503,709 $19.2 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $2.87 Million - $4.25 Million	-71,579 Reduced 11.08%	574,194 $32.7 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $1.69 Million - $2.27 Million	43,762 Added 7.27%	645,773 $25.5 Million
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $1.49 Million - $1.93 Million	39,961 Added 7.11%	602,011 $26.5 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $713,186 - $915,966	22,308 Added 4.13%	562,050 $22.4 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $281,320 - $360,270	-8,841 Reduced 1.61%	539,742 $21.7 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $7.52 Million - $9.08 Million	195,504 Added 55.37%	548,583 $22.3 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $93,138 - $123,041	-2,398 Reduced 0.67%	353,079 $16 Million
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $909,559 - $1.18 Million	23,021 Added 6.92%	355,477 $14.8 Million
Q4 2020 Feb 12, 2021	SELL	$25.81 - $43.62 $47,722 - $80,653	-1,849 Reduced 0.55%	332,456 $14.2 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $58,017 - $66,786	-2,254 Reduced 0.67%	334,305 $8.79 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $113,457 - $187,187	-6,982 Reduced 2.03%	336,559 $9.02 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $1.57 Million - $2.47 Million	113,253 Added 49.18%	343,541 $6.18 Million
Q4 2019 Feb 28, 2020	BUY	$14.93 - $19.53 $1.53 Million - $2 Million	102,446 Added 80.13%	230,288 $4.08 Million
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $589,794 - $771,513	-39,504 Reduced 23.61%	127,842 $4.08 Million
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $154,644 - $179,978	-10,174 Reduced 5.73%	167,346 $2.6 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $2,079 - $2,433	-141 Reduced 0.08%	177,520 $3.05 Million
Q1 2019 May 13, 2019	SELL	$13.94 - $17.58 $814,165 - $1.03 Million	-58,405 Reduced 24.74%	177,661 $2.86 Million
Q4 2018 Feb 12, 2019	SELL	$13.33 - $18.66 $4.78 Million - $6.69 Million	-358,468 Reduced 60.29%	236,066 $3.45 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $227,765 - $251,388	-13,655 Reduced 2.25%	594,534 $10.8 Million
Q2 2018 Aug 14, 2018	BUY	$16.87 - $20.3 $1.58 Million - $1.9 Million	93,544 Added 18.18%	608,189 $10.3 Million
Q1 2018 May 14, 2018	BUY	$17.06 - $21.2 $113,739 - $141,340	6,667 Added 1.31%	514,645 $10.1 Million
Q4 2017 Feb 13, 2018	SELL	$16.75 - $20.8 $963,979 - $1.2 Million	-57,551 Reduced 10.18%	507,978 $10.3 Million
Q3 2017 Nov 13, 2017	BUY	$11.76 - $17.4 $6.65 Million - $9.84 Million	565,529	565,529 $9.82 Million

Others Institutions Holding HALO

# of Institutions

536

Shares Held

124M

Call Options Held

177K

Put Options Held

167K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.52B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Account

Kennedy Capital Management, Inc. Halozyme Therapeutics, Inc. Transaction History